A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...

May 21, 2025 • We asked some of our trusted critics which upcoming books they are most looking forward to. Here are the fiction and nonfiction titles they picked.

He served as the science, environment and aerospace correspondent and the anchor of various programs, including American Morning. While at CNN, O’Brien secured a deal with NASA to become the ...